Quick summary of breach of directors duties and shareholder oppression
Not automatically. In Our Jim & Felicja Superfund v Lindenfels [2026] FCA 307, the Federal Court held that whether conduct is oppressive under section 232 of the Corporations Act 2001 (Cth) is not materially assisted by asking whether it breaches a fiduciary duty. It dismissed every claim by minority shareholders of Batchfire Resources, including that dilutive rights issues were oppressive.
Key Insights
- Oppression under s 232 is judged by commercial unfairness; proving a breach of duty does not by itself establish oppression.
- A majority investor acting under arm’s length commercial contracts did not owe fiduciary duties to the company in respect of those contracts.
- A dilutive rights issue is not oppressive where it is a genuine response to the company’s need for capital.
- Nominee directors owe the same duties as other directors, but those duties accommodate the commercial reality of their appointment.
- A director cannot be ordered under s 233 to compensate the company for breaching statutory duties; that claim belongs in a derivative action.
On this page
- Quick summary
- What was Superfund v Lindenfels about?
- Did the majority investor owe fiduciary duties?
- Was a fair market price term implied?
- Is a dilutive rights issue oppressive?
- What must a nominee director disclose to the board?
- Can an oppression claim recover compensation for a director’s breach?
- Practical tips for minority shareholders
- Frequently asked questions
- Key takeaways
- Our approach
- Further reading
- Links and further references
In Our Jim & Felicja Superfund Pty Ltd as trustee for the Jim & Felicja Superannuation Fund v Lindenfels Pte Ltd [2026] FCA 307 (Superfund v Lindenfels), Halley J dismissed claims by minority shareholders of Batchfire Resources Pty Ltd (Batchfire) for breach of fiduciary duty, an implied contractual term, oppression and breach of directors’ duties.[1] The case is a reminder that shareholder oppression under section 232 of the Corporations Act 2001 (Cth) (Corporations Act) must be established on its own terms, even where the claim relies on alleged breaches of fiduciary or statutory duties. For an overview of shareholder oppression, see our shareholder oppression lawyers page.
——— Background
What was the case of Superfund v Lindenfels about?
Minority shareholders in Batchfire alleged that its majority investor made the company a captive supplier of coal for the investor’s profit and then used dilutive rights issues to take control.
In 2016, Batchfire acquired the Callide Mine. An investment by Avra Commodities Pte Ltd (Avra), through its special purpose vehicle Lindenfels Pte Ltd (Lindenfels), made it Batchfire’s majority shareholder. As a condition of the investment, Batchfire entered into an Agency Agreement appointing Avra as its exclusive marketing agent and an Offtake Agreement allowing Avra to buy coal directly. The plaintiffs alleged that Avra and its nominee director, Mr Ben Burgess, deprived Batchfire of coal sale revenue and that the 2019 and 2020 rights issues were oppressive.[2]
| Claim | Result | Key reason |
|---|---|---|
| Breach of fiduciary duty by Avra (no profit and no conflict rules) | Dismissed | The relationship was commercial and the contract permitted Avra to buy coal |
| Implied term requiring a fair market price | Dismissed | The term failed the conditions for implying a term |
| Oppression under ss 232 and 233 | Dismissed | The conduct was contractually authorised and the rights issues met a genuine need for capital |
| Breach of directors’ duties by Mr Burgess (ss 180–182 and equitable duties) | Dismissed | No duty to disclose Avra’s commercially sensitive on-sale contracts |
In short, every claim failed, and the plaintiffs were ordered to pay the defendants’ costs.[3]
——— Fiduciary duties
Did the majority investor owe fiduciary duties?
No. The Court held that Avra did not owe fiduciary obligations to Batchfire in respect of its contractual duty to provide “Marketing Activities” under the Agency Agreement, because the relationship between the parties was commercial.[4]
The plaintiffs alleged that Avra breached the no profit rule, by taking advantage of an opportunity or knowledge derived from its position without informed consent, and the no conflict rule, by advancing its own interests where there was a real or substantial possibility of conflict with Batchfire’s interests.[5] The Court also found that:[6]
- clause 4.1(a) of the Agency Agreement expressly permitted Avra to buy Export Coal “instead of providing Marketing Activities”, and imposing a fiduciary duty would have altered the operation of that right;
- Avra’s right to buy Export Coal under the Offtake Agreement did not depend on its performance of the Marketing Activities;
- any fiduciary duty would not have prevented Avra buying Export Coal and reselling it to end-users at a profit; and
- the explanatory statement given to shareholders before the investment was sufficient to constitute informed consent to the potential conflict.
In short, a majority investor dealing with the company under arm’s length contracts will not easily be treated as a fiduciary.
——— Implied terms
Was a fair market price term implied?
No. The plaintiffs argued that the Agency Agreement contained an implied term requiring Avra to pay a fair market price for coal bought under the Offtake Agreement. The Court found the alleged term failed all five (5) conditions for implying a term into a contract:[7]
- reasonable and equitable: the Agency Agreement was the result of an arm’s length commercial negotiation;[8]
- business efficacy: the term was not necessary, because Batchfire could refuse to agree a price, which would trigger Avra’s obligation to market the coal as agent;[9]
- so obvious it goes without saying: both parties knew Avra would buy at a wholesale price that allowed for its own margin, and it would make no commercial sense for Avra to buy at “a fair market price” and resell at that same price;[10]
- clear expression: “fair market price” was imprecise in context;[11] and
- consistency with the express terms: purchases under the Offtake Agreement were made “instead of” Avra conducting the Marketing Activities, so the term did not fit the agreement as written.[12]
In short, courts will not imply a pricing term into a negotiated commercial agreement simply because one party later considers the price unfair.
——— Oppression
Can a dilutive rights issue be oppressive?
Not if it is a genuine response to the company’s need for capital. The Court held that the need for the 2019 and 2020 rights issues would have arisen regardless of the conduct of Avra, Lindenfels or Mr Burgess, so the rights issues were not engineered to dilute the minority.[13]
Section 232 allows the Court to make orders under section 233 where the conduct of a company’s affairs, an act or omission, or a resolution is contrary to the interests of the members as a whole, or oppressive to, unfairly prejudicial to, or unfairly discriminatory against, a member. The question is whether the conduct is commercially unfair.[14]
The Court found that the Coal Trading Contract, under which coal was alleged to have been bought at an undervalue, was not oppressive. It was made under express contractual rights, its prices were approved by Batchfire’s CEO and they were higher than the prices in Batchfire’s domestic supply contracts.[15]
Importantly, the Court said that whether conduct is oppressive is not materially assisted by asking whether it is unlawful or a breach of fiduciary duty.[16] A dilutive rights issue that is a commercially necessary response to financial distress is not oppressive.[17]
In short, minority shareholders must prove commercial unfairness, not just that the majority profited or that their shareholding was diluted.
——— Directors’ duties
What must a nominee director disclose to the board?
Not every commercially sensitive matter known to their appointer. The plaintiffs alleged that Mr Burgess breached his duties of care and diligence, good faith and proper use of position under sections 180, 181 and 182 of the Corporations Act by failing to disclose Avra’s profit margins and on-sale contracts to the Batchfire board.[18] The Court found that:
- nominee directors owe the same duties as other directors, but their obligations must accommodate the commercial reality of the relationship between the company and their appointer;[19]
- Mr Burgess was not required to disclose Avra’s on-sale contracts or profit margins, which were commercially sensitive, and the board already knew Avra was making a profit as part of the price of its investment;[20]
- Batchfire’s amended constitution permitted nominee directors to communicate company information to their appointer, and there was no evidence Mr Burgess used Batchfire’s financial distress to secure an improper advantage for Avra;[21] and
- the existence of Avra’s long-term contracts was disclosed in board papers in January 2019.[22]
In short, a nominee director must act in the company’s interests, but is not required to disclose every commercially sensitive matter known to their appointer.
——— Relief and valuation
Can an oppression claim recover compensation for a director’s breach?
No. The Court held that an order cannot be made under section 233 requiring a director to compensate the company for breaching statutory directors’ duties. That claim must generally be brought as a derivative action under section 236.[23]
| Oppression application | Derivative action | |
|---|---|---|
| Provisions | ss 232–234 | ss 236–237 |
| Whose loss | The member’s own position | The company’s loss |
| Typical outcome | Buy-out, regulation of the company’s affairs or other s 233 orders | Compensation or damages paid to the company |
| Court’s leave needed | No | Yes |
Although the claims failed, the Court also addressed valuation. Had oppression been established, the plaintiffs’ expert’s discounted cash flow valuation would have been the starting point for valuing their shares, with an eighty percent (80%) discount applied to reflect the risks and operational challenges Batchfire faced regardless of the conduct.[24]
In short, an oppression application is not a substitute for a derivative action where the real complaint is a director’s breach of duty to the company.
Concerned about a director’s conduct or a dilutive capital raising? Dundas Lawyers advises minority shareholders and directors on oppression claims, directors’ duties and derivative actions. Call 07 3221 0013 or submit an enquiry online.
——— Practical tips
Practical tips for minority shareholders
Frame the oppression case on its own terms
Show how the conduct is commercially unfair to you as a member. A breach of duty alone will not establish oppression.
Read the investment documents
Express contractual rights and shareholder disclosure can authorise conduct, or amount to informed consent, that might otherwise look unfair.
Test the company’s need for capital
Before alleging a dilutive rights issue is oppressive, consider whether the company genuinely needed the funds.
Choose the right proceeding
Claims for loss suffered by the company, such as a director’s breach of duty, generally require a derivative action with the Court’s leave.
See also our article on whether a commercial purpose can excuse shareholder oppression.
Frequently asked questions about breach of duty and oppression
Is a breach of directors’ duties automatically shareholder oppression?
No. In Our Jim & Felicja Superfund v Lindenfels [2026] FCA 307, the Federal Court held that whether conduct is oppressive under section 232 of the Corporations Act is not materially assisted by asking whether it is unlawful or breaches a fiduciary duty. The question is whether the conduct is commercially unfair.
Is a dilutive rights issue oppressive to minority shareholders?
Not if it is a genuine and commercially necessary response to the company’s need for capital. A rights issue may be oppressive if it is engineered to dilute the minority rather than to raise needed funds.
Does a majority shareholder owe fiduciary duties to the company?
Not merely because it is a majority shareholder. In Superfund v Lindenfels, the Court held that the majority investor did not owe fiduciary duties in respect of its contractual marketing obligations because the relationship was commercial.
What does a nominee director have to disclose to the board?
A nominee director owes the same duties as any other director, but those duties accommodate the commercial reality of the appointment. In Superfund v Lindenfels, the nominee director was not required to disclose his appointer’s commercially sensitive on-sale contracts or profit margins.
Can I recover compensation for a director’s breach through an oppression claim?
Generally, no. The Court cannot order a director under section 233 to compensate the company for breaching statutory directors’ duties. That claim is usually brought as a derivative action under section 236, which requires the Court’s leave.
How are shares valued if oppression is proven?
It depends on the evidence. In Superfund v Lindenfels, the Court said it would have started with a discounted cash flow valuation but applied an 80% discount to reflect the risks the company faced regardless of the conduct.
Key takeaways about breach of duty and oppression
- Every claim in Superfund v Lindenfels failed, including breach of fiduciary duty, implied term, oppression and directors’ duties.
- A majority investor acting under arm’s length commercial contracts did not owe fiduciary duties to the company in respect of those contracts.
- Courts will not imply a fair market price term into a negotiated commercial agreement that does not need it.
- Oppression requires commercial unfairness; a breach of duty or a dilutive rights issue is not enough on its own.
- Nominee directors owe full duties, but need not disclose their appointer’s commercially sensitive information where the board knows the commercial arrangement.
- Compensation for a director’s breach is generally pursued through a derivative action under section 236, not an oppression order.
Need advice about shareholder oppression or directors’ duties? Call Dundas Lawyers on 07 3221 0013 or submit an enquiry online.
Our approach to oppression and directors’ duties disputes
Dundas Lawyers acts for minority shareholders, investors and directors in shareholder and directors’ duties disputes. We assess whether the conduct is genuinely oppressive or better pursued as a derivative action, test the commercial documents and valuation evidence early, and choose the most likely method of delivering a practical outcome.
Further reading about shareholder oppression
For further reading on breach of duty and shareholder oppression, see the following articles written by the team at Dundas Lawyers.
- Commercial purpose and oppression – whether conduct with a commercial purpose can still be oppressive, in Hylepin v Doshay. See: Can a ‘commercial purpose’ excuse shareholder oppression?
- Third-party liability – when accountants may be exposed in oppression claims. See: Accountant liability in shareholder oppression cases
- Director misconduct as oppression – a case where a director’s misuse of funds was held to be oppressive. See: Director’s misuse of funds held to be oppressive
- Valuation in oppression claims – how shares are valued once oppression is proven. See: Shareholder oppression – valuation issues
- Remedies for oppression – when the Court orders a buy-out or winding up. See: Shareholder oppression remedies: buy-out or winding up?
Links and further references
Legislation
Corporations Act 2001 (Cth) ss 180, 181, 182, 232, 233, 236, 237
Cases
Further information
If you need assistance about shareholder oppression or directors’ duties, contact us for a confidential and obligation‑free discussion.

Malcolm Burrows B.Bus.,MBA.,LL.B.,LL.M.,MQLS.
Legal Practice Director
T: +61 7 3221 0013 (preferred)
M: +61 419 726 535
E: mburrows@dundaslawyers.com.au

Disclaimer
This article contains general commentary only. You should not rely on the commentary as legal advice. Specific legal advice should be obtained to ascertain how the law applies to your particular circumstances.
[1] Our Jim & Felicja Superfund Pty Ltd as trustee for the Jim & Felicja Superannuation Fund v Lindenfels Pte Ltd [2026] FCA 307, [12]–[13].
[2] Superfund v Lindenfels (n 1) [9].
[3] Superfund v Lindenfels (n 1) [13].
[4] Superfund v Lindenfels (n 1) [12(a)].
[5] Superfund v Lindenfels (n 1) [7].
[6] Superfund v Lindenfels (n 1) [12].
[7] Superfund v Lindenfels (n 1) [352].
[8] Superfund v Lindenfels (n 1) [353].
[9] Superfund v Lindenfels (n 1) [354].
[10] Superfund v Lindenfels (n 1) [355].
[11] Superfund v Lindenfels (n 1) [356].
[12] Superfund v Lindenfels (n 1) [357].
[13] Superfund v Lindenfels (n 1) [12(d)], [338].
[14] Corporations Act 2001 (Cth) s 232; Superfund v Lindenfels (n 1) [358]–[362].
[15] Superfund v Lindenfels (n 1) [335]–[337].
[16] Superfund v Lindenfels (n 1) [12(f)].
[17] Superfund v Lindenfels (n 1) [491].
[18] Superfund v Lindenfels (n 1) [549].
[19] Superfund v Lindenfels (n 1) [588].
[20] Superfund v Lindenfels (n 1) [636]–[637].
[21] Superfund v Lindenfels (n 1) [599].
[22] Superfund v Lindenfels (n 1) [621].
[23] Superfund v Lindenfels (n 1) [12(i)], [821].
[24] Superfund v Lindenfels (n 1) [12(k)]–[12(l)], [799]–[801].
Related insights about shareholder oppression



